hg_118263.1

Basic information about the TSS

---

TSS ID: hg_118263.1 Species: human Chr: chr11		Start: 2992086 End: 2992126 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000430811.5 Distance: 0 GeneID: 4676 HGNC/MGI_ID: HGNC:7640 UniProt_ID: C9J6D1

Gene_name: nucleosome assembly protein 1 like 4 Gene_symbol: NAP1L4 Gene_synonyms: NAP2 Gene_source: HGNC:7640

TATA-Box annotation

---

Distance to TSS:	1
Nearest PromoterID:	NM_001369384
Entrez ID:	4676
Nearest Unigene:	Hs.731784
Nearest Refseq:	NM_005969
Nearest Ensembl:	ENSG00000205531
Gene Name:	nucleosome assembly protein 1 like 4
Gene Alias:	NAP1L4b|NAP2|NAP2L|hNAP2
Gene Description:	nucleosome assembly protein 1 like 4
Gene Type:	protein-coding
CpG%:	0.14
GC%:	0.850746
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NAP1L4 p2@NAP1L4 p3@NAP1L4 p4@NAP1L4 p5@NAP1L4
Sample		p1@NAP1L4	p2@NAP1L4	p3@NAP1L4	p4@NAP1L4	p5@NAP1L4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	58.64	1.17	6.62	1.56	3.90
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	56.45	0.81	7.28	2.02	3.44
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	61.34	1.16	10.61	1.93	4.63
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	54.47	1.04	6.86	1.25	2.70
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	53.54	0.90	4.95	0.90	3.82
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	54.65	0.97	5.62	2.91	2.13
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	72.12	1.09	9.15	1.31	3.92
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	54.50	1.94	10.90	0.97	2.91
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	59.63	0.85	10.04	1.50	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	56.22	0.58	11.59	2.32	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	50.53	0.81	5.66	0.81	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	42.28	0.41	10.98	2.03	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	25.15	3.87	1.93	1.45	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	24.96	4.36	1.65	0.75	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	30.96	5.27	1.32	1.98	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	19.62	2.51	0.75	1.26	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	24.90	2.84	1.31	1.97	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	23.62	2.53	1.69	0.42	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	25.59	3.20	0.00	2.13	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	29.94	3.46	1.35	2.11	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	26.60	4.95	1.47	1.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	26.41	3.11	0.86	2.24	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	23.78	2.46	0.90	2.07	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	24.51	6.31	2.18	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	23.99	3.87	1.81	1.29	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	27.85	3.48	0.63	1.90	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	21.98	4.95	0.00	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	30.18	3.30	1.41	3.06	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	23.42	5.81	0.48	2.10	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	26.60	5.07	1.81	1.63	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	25.75	3.35	1.67	2.09	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.20	4.88	1.56	1.76	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.89	1.69	0.42	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.33	3.13	1.65	1.48	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	24.12	4.11	0.56	2.43	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	24.72	3.83	1.34	3.64	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	26.98	3.27	0.82	1.84	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	26.19	4.03	0.81	2.01	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	31.06	5.13	0.27	1.89	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	23.53	3.36	1.20	1.92	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.47	1.88	0.71	2.35	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	28.55	4.25	1.61	1.17	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	23.41	4.01	1.05	2.74	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	25.35	3.50	0.87	2.10	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	30.32	2.61	0.80	1.61	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	31.41	2.33	1.63	2.33	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.15	3.12	1.68	1.44	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	25.93	4.47	2.09	2.09	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	25.61	2.15	1.44	2.15	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	25.27	3.44	0.40	2.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.67	2.05	0.41	1.84	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	31.13	2.67	1.56	2.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	405.77	0.00	0.00	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	20.58	0.71	2.84	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	20.21	0.66	0.00	1.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	109.06	0.84	1.68	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	50.06	2.76	0.92	3.21	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.66	3.24	0.97	2.92	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	19.59	2.57	0.96	3.21	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	43.06	0.94	2.51	2.83	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.86	0.71	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	19.07	2.24	0.56	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	42.99	0.80	0.00	2.39	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	37.03	0.34	0.68	2.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	18.85	2.60	0.97	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.46	1.42	1.06	1.77	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	307.11	0.00	0.00	16.16	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	300.10	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.48	2.44	0.98	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	25.79	4.46	0.50	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	26.27	4.22	2.35	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	36.76	2.98	0.99	1.99	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	22.58	5.88	0.93	0.93	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	23.24	5.20	0.31	2.14	0.00
Adipocyte - breast, donor1	11376-118A8	29.78	2.85	0.79	0.79	0.79
Adipocyte - breast, donor2	11327-117E4	23.90	3.37	2.41	1.60	0.80
Adipocyte - omental, donor1	11473-119C6	30.03	2.67	0.76	1.02	0.89
Adipocyte - omental, donor2	11474-119C7	16.44	0.75	0.75	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	19.09	1.34	0.67	1.34	0.33
Adipocyte - perirenal, donor1	11476-119C9	22.33	0.00	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	2.20	0.00	2.20	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	3.16	1.35	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	17.03	5.91	1.04	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	33.05	4.11	0.98	0.98	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	18.53	1.54	0.77	1.03	1.80
Adipocyte differentiation, day04, donor3	13025-139E1	28.43	3.35	3.35	0.84	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	28.80	2.94	4.70	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	43.68	8.85	4.34	4.58	2.73
Adipocyte differentiation, day08, donor2	13023-139D8	22.27	3.23	0.97	1.29	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	26.13	3.73	1.07	1.07	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	27.82	3.90	2.78	2.78	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	24.12	4.16	2.91	6.24	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	23.86	2.76	1.76	2.51	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	22.58	3.93	3.27	4.25	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	21.31	1.83	2.74	2.74	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	36.24	2.65	5.75	1.33	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	7.89	1.08	1.08	2.15	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	2.40	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	40.48	5.04	5.22	6.30	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	26.78	6.69	0.00	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	26.71	7.19	3.29	3.90	1.03
Anulus Pulposus Cell, donor1	11248-116E6	47.37	6.75	2.40	5.84	1.26
Anulus Pulposus Cell, donor2	11463-119B5	21.55	5.14	1.96	4.65	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	26.96	1.80	5.84	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	29.09	1.74	2.17	3.04	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	2.14	2.14	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	25.71	2.39	2.39	0.90	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	36.67	5.06	2.53	3.79	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.16	2.64	1.98	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.34	2.92	2.92	1.30	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	23.30	1.94	4.37	1.46	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	26.13	3.56	2.97	2.38	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	31.26	1.51	3.39	1.51	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.85	2.18	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	25.08	1.25	2.51	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	34.43	3.95	2.80	0.99	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	0.00	2.73	2.73	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	23.52	4.37	2.41	2.41	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	25.72	3.75	4.29	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	26.26	2.08	3.59	1.13	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	29.94	2.41	3.47	1.60	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	23.41	0.00	1.95	2.93	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	26.04	4.15	1.99	1.00	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	10.62	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	23.16	2.74	2.74	0.51	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	4.19	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	33.98	2.91	2.43	1.94	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.01	5.31	1.90	1.90	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	32.71	1.21	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	23.94	1.71	2.85	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	29.71	4.06	1.92	2.14	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	22.45	2.84	1.29	1.81	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	33.31	4.22	3.75	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	27.33	2.89	2.25	1.29	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.12	0.71	2.85	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	27.49	2.92	1.75	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	26.80	4.82	3.61	2.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	4.75	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	31.02	3.56	1.02	2.03	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	38.71	4.08	1.78	1.53	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	30.50	1.27	0.00	2.54	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	24.60	3.02	4.32	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	31.33	2.33	5.08	0.64	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	22.91	2.32	4.06	2.03	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	22.67	1.89	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.26	3.90	4.58	2.03	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	9.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	27.23	3.43	3.22	2.36	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	2.41	1.20	2.41	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	21.87	2.92	0.73	1.46	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	28.28	5.06	2.99	1.38	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	19.83	3.05	4.58	1.78	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	27.04	2.48	2.68	1.86	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	25.40	1.22	1.84	0.61	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	32.03	1.43	0.48	1.91	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.39	3.77	2.88	2.00	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	4.58	9.15	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	21.05	2.22	1.66	1.66	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	26.74	4.50	2.38	1.85	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.81	3.63	1.45	1.82	1.09
Astrocyte - cerebellum, donor1	11500-119F6	45.07	4.05	7.12	3.32	2.70
Astrocyte - cerebellum, donor2	11580-120F5	24.99	2.23	3.59	3.42	0.86
Astrocyte - cerebellum, donor3	11661-122F5	17.20	1.47	1.47	1.05	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	100.04	3.49	8.37	8.71	3.49
Astrocyte - cerebral cortex, donor2	11316-117D2	82.18	5.34	6.63	6.79	3.40
Astrocyte - cerebral cortex, donor3	11392-118C6	84.72	4.77	7.46	5.97	2.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	67.44	4.70	6.42	1.61	1.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	75.17	5.51	6.51	2.63	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	73.85	5.12	6.60	2.50	1.48
Basophils, donor1	12241-129G9	15.69	3.66	1.57	0.52	0.78
Basophils, donor2	12242-129H1	47.26	5.41	2.89	0.36	0.72
Basophils, donor3	12243-129H2	16.90	4.12	2.35	0.73	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	12.07	3.02	1.51	2.59	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	2.74	1.83	1.37	1.83	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	25.73	2.51	3.77	3.14	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	15.80	1.25	3.54	2.29	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	14.74	3.45	4.84	2.99	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	23.03	3.78	2.34	3.24	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	82.55	0.93	3.81	0.31	4.95
Burkitt's lymphoma cell line:RAJI	10476-106I8	99.45	2.10	8.15	2.10	5.36
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	52.44	4.80	4.16	1.92	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	16.91	4.51	0.56	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	15.96	2.04	2.78	0.19	0.56
CD14+ Monocytes, donor3	11381-118B4	20.42	4.61	2.85	0.44	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	37.08	5.38	1.42	0.57	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	47.38	7.58	0.76	1.14	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	34.85	7.56	0.99	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	28.04	1.30	2.17	0.00	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	17.50	0.91	0.91	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	20.85	1.42	4.50	0.47	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	14.23	0.84	1.17	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	12.97	1.66	0.83	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	12.15	1.49	1.49	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.05	0.39	1.37	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.50	0.71	0.71	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	11.75	0.44	1.52	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	9.13	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	14.78	0.53	1.06	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	14.42	0.00	3.33	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	15.47	1.19	2.23	0.45	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	14.57	0.60	2.20	0.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	21.65	1.04	2.29	0.00	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	13.27	0.92	0.92	0.69	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	11.76	0.90	1.58	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	11.35	0.87	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	13.72	0.54	1.61	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	11.86	1.74	1.57	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	18.10	1.26	1.26	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.61	0.18	0.92	0.00	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.40	0.00	2.11	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	9.65	0.00	0.88	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.67	0.52	1.22	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.41	2.23	2.23	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	13.15	1.29	1.08	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.15	0.41	1.23	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.27	0.00	0.93	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	13.22	0.70	2.09	0.00	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	25.28	1.31	3.05	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	24.02	1.39	3.46	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	21.23	1.30	3.47	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	27.72	2.02	4.05	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	23.93	2.79	2.10	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	38.13	2.45	4.91	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	23.48	2.04	3.57	0.00	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	25.47	1.76	6.37	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	32.00	1.47	5.47	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	56.90	2.03	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	67.12	1.36	6.78	2.71	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	54.89	3.11	5.18	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	68.23	5.33	5.33	0.00	4.26
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	73.98	2.68	7.50	2.14	3.22
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	59.66	4.21	6.32	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	43.92	2.35	1.57	0.00	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	73.82	6.59	2.64	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	38.63	4.11	8.22	0.82	1.64
CD19+ B Cells, donor2	11624-122B4	52.23	6.53	2.90	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	47.96	2.52	4.04	0.50	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	245.67	12.93	42.02	4.04	12.93
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	170.58	10.39	29.56	1.60	7.59
CD34+ Progenitors, donor1	11545-120B6	26.11	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	33.71	3.37	5.62	1.12	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	67.64	7.14	4.13	3.01	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	76.66	5.41	3.16	1.58	2.48
CD4+ T Cells, donor1	11225-116C1	102.83	11.78	3.93	1.07	10.35
CD4+ T Cells, donor2	11306-117C1	78.38	17.76	3.67	1.22	3.67
CD4+ T Cells, donor3	11382-118B5	75.33	17.38	3.35	0.91	4.88
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	103.12	10.72	4.34	1.02	5.36
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	84.90	8.76	3.59	1.12	4.27
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	72.15	8.91	6.61	2.59	4.02
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	119.00	5.22	4.74	0.47	9.48
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	115.88	10.53	3.51	0.00	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	135.15	0.00	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	108.68	9.54	6.21	3.32	8.82
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	76.77	9.32	7.96	2.54	5.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	72.86	6.13	5.32	2.58	4.51
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	99.52	7.17	5.38	1.34	7.17
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	101.67	10.83	3.84	1.40	3.84
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	145.63	8.36	6.16	0.88	5.72
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	119.75	8.01	8.01	2.53	7.59
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	74.80	6.65	7.90	2.91	2.29
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	69.50	7.68	9.36	2.00	4.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	122.37	6.53	4.62	0.82	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	169.36	8.04	5.36	0.54	5.90
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	91.45	7.17	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	103.65	9.64	8.72	2.97	5.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	84.91	9.10	6.72	3.47	4.33
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	74.81	9.88	5.88	1.26	3.99
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	102.64	11.12	4.04	0.00	4.55
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	85.78	5.63	0.87	1.73	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	153.84	9.15	3.49	0.87	5.23
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	154.40	12.87	9.90	1.48	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	118.17	10.16	5.54	0.00	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	128.42	8.37	2.79	2.79	6.98
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	127.94	9.14	6.37	0.83	8.31
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	158.77	9.57	7.61	0.74	9.57
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	135.52	4.62	4.62	0.00	6.16
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	139.67	13.61	5.37	1.07	3.58
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	132.96	15.23	5.54	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	76.28	12.77	2.62	0.33	4.91
CD8+ T Cells, donor2	11307-117C2	51.81	9.76	3.00	1.13	4.13
CD8+ T Cells, donor3	11383-118B6	103.27	12.88	3.79	1.26	8.58
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	32.80	2.75	7.34	3.21	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	29.00	2.64	8.15	1.68	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	35.02	2.19	4.38	2.46	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	42.63	1.50	8.41	1.80	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	23.52	2.16	5.28	2.16	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	30.47	2.50	3.41	2.73	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	44.33	0.87	5.21	3.26	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	40.27	2.11	5.79	2.37	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	34.47	2.58	4.69	3.52	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	38.94	3.02	4.83	3.32	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	38.64	3.49	6.68	4.36	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	41.56	3.20	6.66	2.13	2.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	29.77	3.50	5.25	3.50	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.96	1.82	0.46	3.64	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.90	1.49	5.22	1.49	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	29.17	2.16	3.60	0.72	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	29.92	2.01	4.32	2.88	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	32.29	2.36	4.01	2.59	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	59.26	0.95	5.70	3.17	2.22
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	44.90	1.85	8.61	4.61	2.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	43.92	3.85	6.09	2.24	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	40.92	0.76	4.21	3.06	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	36.65	2.76	6.31	1.97	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	24.96	1.51	3.78	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	32.12	1.61	5.62	3.21	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	41.97	2.80	2.10	4.20	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	39.07	2.00	3.01	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	21.93	3.66	5.48	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	17.79	0.99	0.99	1.48	0.99
Cardiac Myocyte, donor3	11686-122I3	24.20	2.53	1.58	0.32	0.74
Chondrocyte - de diff, donor1	11261-116G1	33.63	2.08	4.16	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	20.97	1.07	0.71	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	22.98	5.69	1.25	1.48	0.91
Chondrocyte - re diff, donor2	11339-117F7	105.64	0.00	6.27	1.79	2.69
Chondrocyte - re diff, donor3	11411-118E7	22.65	2.83	0.40	1.21	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	92.95	5.74	9.41	5.97	3.67
Ciliary Epithelial Cells, donor2	11323-117D9	55.15	5.13	5.13	7.91	3.21
Ciliary Epithelial Cells, donor3	11399-118D4	57.17	7.35	6.64	5.66	2.92
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	64.01	11.37	8.99	3.21	1.93
Corneal Epithelial Cells, donor1	11526-119I5	10.54	2.42	0.66	1.10	0.44
Corneal Epithelial Cells, donor2	11606-120I4	17.06	1.14	3.41	1.14	2.28
Corneal Epithelial Cells, donor3	11687-122I4	23.26	4.86	2.30	3.83	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	8.42	1.16	0.33	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	10.72	2.52	0.63	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	9.83	1.62	1.30	0.11	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	31.09	5.12	1.37	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	32.64	3.92	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	26.62	2.42	1.94	0.00	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	39.69	3.67	6.34	2.84	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	25.23	2.93	1.76	2.35	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	41.57	2.83	4.24	1.70	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	34.21	2.75	4.33	0.39	1.18
Endothelial Cells - Artery, donor1	11264-116G4	24.14	3.78	2.91	1.16	0.87
Endothelial Cells - Artery, donor2	11341-117F9	23.53	4.47	3.29	2.35	0.47
Endothelial Cells - Artery, donor3	11413-118E9	30.68	2.98	4.03	1.93	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	42.11	6.65	2.66	4.43	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	41.38	5.78	5.48	1.83	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	43.41	5.64	2.26	5.36	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	18.72	3.27	4.46	1.49	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	28.12	2.60	4.69	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	18.29	4.54	2.84	3.12	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	31.61	3.60	6.00	2.00	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	14.15	4.19	0.52	3.14	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	96.29	8.70	9.82	2.61	2.48
Endothelial Cells - Umbilical vein, donor2	11324-117E1	48.01	6.74	8.47	2.39	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	61.67	6.47	8.18	2.56	1.71
Endothelial Cells - Vein, donor1	11267-116G7	19.34	2.28	0.00	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	25.84	2.79	4.89	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	38.00	4.40	3.45	2.20	1.41
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	31.35	4.95	6.60	0.00	0.00
Eosinophils, donor3	12246-129H5	24.97	0.00	7.13	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	13.19	4.40	1.95	2.20	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	2.08	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	27.50	5.34	1.64	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.14	3.72	1.42	1.53	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	22.10	3.14	1.52	1.19	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	45.97	3.27	3.15	0.97	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	40.12	3.96	0.96	0.96	2.87
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.20	3.38	1.05	0.63	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	34.52	0.26	1.84	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	39.86	3.32	4.98	1.99	1.33
Fibroblast - Cardiac, donor1	11268-116G8	26.76	0.91	2.27	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	10.61	0.00	3.79	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	17.98	3.79	1.26	1.10	0.63
Fibroblast - Cardiac, donor4	11452-119A3	39.71	5.76	3.64	3.64	0.30
Fibroblast - Cardiac, donor5	11456-119A7	29.31	2.92	1.65	1.78	1.27
Fibroblast - Cardiac, donor6	11460-119B2	37.14	3.64	1.82	1.06	1.82
Fibroblast - Choroid Plexus, donor1	11492-119E7	39.53	3.08	3.08	4.02	2.68
Fibroblast - Choroid Plexus, donor2	11572-120E6	32.36	1.73	2.59	5.18	3.02
Fibroblast - Choroid Plexus, donor3	11653-122E6	46.87	2.93	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	19.83	3.46	2.54	0.69	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	34.09	4.58	1.53	2.71	0.85
Fibroblast - Dermal, donor1	11269-116G9	18.78	5.63	5.40	0.70	0.70
Fibroblast - Dermal, donor2	11346-117G5	34.90	2.36	8.02	0.94	1.89
Fibroblast - Dermal, donor3	11418-118F5	20.19	6.17	2.90	1.33	0.36
Fibroblast - Dermal, donor4	11450-119A1	55.96	2.94	6.90	1.24	1.36
Fibroblast - Dermal, donor5	11454-119A5	56.87	2.27	9.07	0.70	1.57
Fibroblast - Dermal, donor6	11458-119A9	73.25	3.41	8.45	1.62	1.30
Fibroblast - Gingival, donor1	11237-116D4	46.85	8.95	3.54	1.46	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	39.56	2.62	1.83	1.31	1.57
Fibroblast - Gingival, donor2	11318-117D4	67.47	5.14	4.61	2.24	1.19
Fibroblast - Gingival, donor3	11394-118C8	29.01	7.15	1.26	1.55	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	42.59	5.19	0.00	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	25.37	3.52	1.23	0.53	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	60.80	5.92	6.24	2.34	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	52.47	3.65	6.09	2.84	1.35
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	9.53	1.06	1.76	1.76	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	46.36	4.39	3.80	1.02	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	58.36	4.09	7.50	2.86	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	69.11	4.06	7.02	2.41	1.43
Fibroblast - Gingival, donor9 (control)	11927-125I1	33.31	3.82	2.05	1.61	0.00
Fibroblast - Lung, donor1	11270-116H1	8.16	1.36	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	49.24	2.98	5.97	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	37.14	6.54	3.80	3.38	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	2.50	3.33	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	0.00	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.64	1.68	0.84	0.84	0.00
Fibroblast - Mammary, donor1	11540-120B1	44.66	4.47	4.47	2.03	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	84.18	4.46	9.31	1.36	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	73.26	4.10	7.74	1.21	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	54.16	7.34	8.26	0.61	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	39.69	3.05	5.34	1.14	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	35.64	2.43	3.24	0.81	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	25.98	3.71	1.86	1.28	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	53.72	3.65	4.86	1.55	2.10
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	28.85	4.27	4.27	1.83	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	22.05	2.00	4.01	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	23.33	5.93	2.37	1.98	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	55.37	0.79	2.58	1.39	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.24	3.55	2.31	1.24	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	36.07	2.37	2.76	0.59	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	36.70	0.00	3.91	0.90	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	41.13	2.81	2.81	1.19	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	31.13	0.76	1.27	0.00	1.01
Fibroblast - skin normal, donor1	11553-120C5	34.46	3.61	2.13	0.98	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	64.16	2.21	4.21	1.80	1.40
Fibroblast - skin normal, donor2	11561-120D4	49.63	2.21	5.32	1.91	1.51
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	65.28	0.91	1.81	0.91	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	40.26	4.47	1.41	0.25	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	40.52	2.39	1.71	0.34	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	35.14	0.66	1.97	0.33	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	53.47	3.20	5.01	2.45	1.81
Fibroblast - skin walker warburg, donor1	11554-120C6	57.18	2.36	4.55	1.18	2.19
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	39.99	2.51	0.47	0.31	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	864.23	22.16	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	45.32	6.97	2.61	4.36	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	45.42	6.93	4.68	6.93	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	41.12	7.03	4.94	4.42	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	37.30	8.43	4.85	7.15	2.81
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	63.54	2.30	19.90	5.36	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	70.83	3.19	12.12	5.74	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	122.09	7.13	20.82	8.56	5.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	82.18	2.48	4.96	0.83	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	62.33	2.97	6.39	5.25	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	82.03	7.13	10.50	4.36	2.77
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	73.49	2.11	4.49	1.59	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	48.60	3.91	9.13	3.91	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	107.02	7.52	16.80	5.75	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	76.31	3.82	7.77	5.79	2.69
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	63.66	2.71	5.66	3.57	1.60
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	49.96	4.30	8.33	4.57	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	61.08	2.23	2.48	1.73	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	74.06	1.66	3.46	1.52	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	50.83	2.85	5.08	1.83	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	49.06	4.11	2.74	3.88	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	59.67	2.37	4.11	4.11	1.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	50.71	4.15	4.81	6.56	1.53
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	56.14	2.36	2.07	1.48	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	59.93	1.91	3.66	3.81	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	43.34	4.02	3.57	3.13	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	57.47	2.42	4.23	1.61	2.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	84.99	2.04	4.24	2.37	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	68.01	3.19	3.72	4.88	2.57
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	52.44	2.29	1.98	3.23	1.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	58.92	1.20	0.85	3.24	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	64.29	3.54	1.66	4.20	2.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	66.56	2.25	3.00	3.66	2.41
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	65.34	1.43	4.08	4.29	2.45
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	64.16	2.68	2.27	3.30	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	62.03	3.34	1.27	2.42	1.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	52.03	2.00	2.67	4.17	1.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	40.34	3.09	2.65	4.41	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	60.02	1.35	0.86	3.57	2.21
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	54.63	2.92	2.11	3.57	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	44.90	2.57	0.96	3.53	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	54.01	3.13	1.42	5.59	1.99
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	46.82	2.21	0.95	5.38	1.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	42.88	5.47	2.43	4.26	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	55.93	2.30	1.46	5.02	2.51
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	36.67	2.63	1.76	5.49	2.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	40.68	0.56	2.52	4.49	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	46.66	3.06	2.13	7.22	2.69
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	44.39	1.87	3.21	9.36	1.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	43.45	2.60	3.37	7.19	2.75
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.32	2.07	1.81	7.51	2.59
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	48.52	4.07	1.90	9.49	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	45.35	4.06	1.84	6.08	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	44.30	2.85	1.10	2.41	3.07
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	35.70	3.97	0.99	5.95	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	37.46	2.77	2.24	4.88	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.13	3.43	1.61	2.62	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	33.29	3.30	0.51	3.56	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	73.06	2.59	13.74	9.95	4.78
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	73.49	2.93	5.70	2.16	2.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	102.91	4.09	12.68	7.36	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	66.34	3.44	11.27	5.32	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	62.16	4.80	9.61	4.24	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	73.33	1.38	14.30	4.61	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	51.97	0.00	9.90	2.47	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	88.97	3.87	16.25	6.58	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	48.13	3.21	8.02	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	52.16	0.00	15.65	3.48	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	69.65	1.63	10.42	3.91	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	95.13	2.47	12.35	4.53	3.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	99.97	3.33	6.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	74.67	2.80	7.83	3.08	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	68.31	2.29	9.15	5.56	4.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	51.17	3.36	10.07	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	69.66	2.23	4.77	1.27	3.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	66.91	1.70	9.51	2.38	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	73.09	0.00	14.62	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	83.61	1.72	5.73	0.57	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	58.01	1.18	7.70	1.18	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	66.07	1.69	6.78	1.69	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	83.26	0.41	10.77	4.56	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	74.79	2.07	6.44	1.61	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	55.74	0.38	5.38	1.54	2.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	52.48	3.26	5.87	0.98	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	54.84	1.34	2.68	2.68	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	77.82	1.54	2.70	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	78.40	2.74	6.85	4.79	2.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	62.12	4.97	4.97	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	78.80	2.36	1.42	0.94	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	72.42	1.21	4.22	1.81	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	69.69	1.53	5.09	3.56	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	67.00	1.60	1.99	1.60	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	75.98	1.48	2.47	2.96	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	75.55	1.18	1.18	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	59.51	1.17	7.58	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	65.83	2.19	3.51	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	48.32	2.54	3.39	2.54	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	56.11	3.58	2.39	4.18	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	53.86	0.49	6.31	2.91	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	22.83	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	25.78	2.08	1.25	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	2.25	3.37	1.12	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	25.69	4.12	1.27	1.90	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	21.72	4.18	1.67	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	55.24	2.67	8.12	6.50	3.13
Hep-2 cells mock treated, biol_rep2	11899-125E9	53.17	2.53	8.44	7.26	5.06
Hep-2 cells mock treated, biol_rep3	11900-125F1	50.96	4.10	11.38	5.69	7.74
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	50.28	2.95	9.73	4.81	3.83
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	54.16	3.22	10.10	6.66	4.51
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	47.58	3.66	9.69	6.67	3.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	46.58	3.11	8.72	6.73	3.61
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	51.46	1.89	8.75	4.63	3.60
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	38.44	0.96	11.21	4.16	3.84
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	22.38	2.24	4.48	3.36	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	15.58	2.60	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	0.00	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	21.16	2.12	1.41	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	15.26	1.45	1.45	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	38.29	4.20	4.02	0.52	1.40
Hepatocyte, donor1	11523-119I2	12.11	4.84	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	25.86	4.31	2.15	0.00	1.08
Hepatocyte, donor3	11684-122I1	26.38	2.45	2.45	1.84	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	101.17	1.96	11.75	0.00	4.57
Intestinal epithelial cells (polarized), donor1	11246-116E4	73.23	4.02	5.77	7.34	4.02
Iris Pigment Epithelial Cells, donor1	11530-119I9	39.93	4.12	3.43	2.74	1.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	1.38	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	0.00	0.00	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	2.56	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	4.57	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	1.32	0.00	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	29.93	1.11	2.22	3.33	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	5.24	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.08	0.63	1.89	1.26	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	3.09	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	28.43	2.58	1.94	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	20.93	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.00	0.00	0.81	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	14.27	0.84	1.68	1.26	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	24.91	0.80	0.80	0.80	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	17.54	3.69	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	21.24	1.89	1.42	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	17.23	0.91	2.72	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	16.14	4.30	0.00	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	13.98	2.54	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.30	1.28	0.64	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	1.82	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	20.71	0.71	2.86	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	30.25	2.16	3.09	0.93	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	1.76	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00	6.29	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	14.60	1.39	0.70	0.00	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	0.00	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	14.82	1.74	3.49	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	4.50	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	3.48	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	18.14	5.33	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	0.92	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	14.80	1.06	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	24.40	3.75	3.43	2.45	1.71
Keratinocyte - epidermal, donor2	11349-117G8	12.88	0.59	2.34	0.59	2.34
Keratinocyte - epidermal, donor3	11421-118F8	40.13	7.19	3.98	2.27	1.42
Keratinocyte - oral, donor1	11251-116E9	58.23	10.33	3.97	3.75	2.38
Keratocytes, donor1	11527-119I6	19.25	2.41	2.06	0.00	0.00
Keratocytes, donor2	11607-120I5	11.72	3.52	5.86	0.00	0.00
Keratocytes, donor3	11688-122I5	24.70	1.58	0.40	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	57.15	8.79	17.58	4.40	2.20
Lens Epithelial Cells, donor1	11529-119I8	35.60	3.24	8.63	1.08	2.16
Lens Epithelial Cells, donor2	11609-120I7	79.58	6.34	11.53	5.77	5.31
Lens Epithelial Cells, donor3	11690-122I7	36.53	5.85	1.41	3.53	1.92
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	38.66	4.27	4.62	1.42	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	23.72	1.40	1.95	1.12	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	36.36	3.94	3.78	1.42	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	24.20	2.15	2.69	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	20.80	1.58	3.47	0.95	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.26	2.59	2.26	0.97	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	29.14	0.41	2.87	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.69	1.52	4.05	0.76	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	25.05	2.96	3.10	0.28	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	26.11	2.37	2.37	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.98	1.74	2.71	0.58	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.22	1.48	1.67	0.19	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	33.45	2.44	1.74	1.05	2.09
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	25.76	3.82	1.67	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.11	2.61	2.06	0.69	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	24.02	2.16	2.77	1.54	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.59	1.87	1.25	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	22.32	4.57	2.74	0.91	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	22.05	2.96	2.96	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	17.87	0.59	2.34	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	16.18	1.49	1.49	0.75	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	22.31	2.91	3.39	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	23.43	1.89	3.77	1.35	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	28.46	2.42	2.88	1.36	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	19.18	0.52	4.15	0.00	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	24.92	2.51	1.26	0.63	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	22.26	2.86	1.50	1.05	1.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	19.26	1.38	2.06	1.38	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	23.71	1.69	2.26	0.56	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	18.98	2.01	1.80	1.27	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	23.74	1.94	0.97	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	16.54	1.32	1.65	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	19.57	2.60	2.60	0.74	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	28.14	1.48	1.85	1.11	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	18.78	1.73	1.24	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.42	2.20	2.75	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	30.56	2.89	3.54	0.00	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	21.91	1.22	2.43	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	27.57	4.34	4.48	1.40	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	30.22	2.13	1.78	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.03	2.42	0.97	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.32	2.18	1.56	0.93	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	30.44	2.51	1.79	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	15.68	1.31	1.96	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	17.42	2.83	2.12	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	33.29	1.49	4.08	1.73	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.55	2.31	0.51	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	22.08	1.19	2.09	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	2.27	4.53	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.95	3.07	6.14	1.53	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	18.56	0.00	2.97	3.71	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	19.04	1.69	6.77	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	17.58	0.70	2.11	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	22.42	0.00	3.74	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	21.13	3.09	7.21	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	2.38	9.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	19.23	2.94	3.39	2.04	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	24.43	4.94	6.40	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.96	2.25	4.95	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	23.44	3.25	4.61	1.35	1.22
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.51	3.08	3.59	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	16.94	1.41	8.47	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	19.32	1.33	5.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	21.39	1.02	6.62	1.53	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	26.68	2.67	7.20	1.60	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.37	3.21	5.29	1.70	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.86	2.45	4.91	1.84	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	24.46	3.26	4.89	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	22.28	2.50	5.83	1.04	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	27.75	2.52	5.32	1.40	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	23.70	1.03	4.12	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.10	2.03	6.39	3.48	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	23.32	3.59	5.38	0.90	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.22	2.77	8.30	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.21	1.41	6.01	1.77	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.13	2.95	5.16	1.11	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	17.27	2.30	2.30	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.41	1.92	8.44	1.92	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	13.02	1.70	1.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	15.59	0.00	4.10	3.28	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	19.88	1.81	5.87	2.26	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	13.64	1.44	6.46	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	25.39	3.73	4.48	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.18	3.34	6.32	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	17.66	3.02	6.46	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	9.42	2.57	5.14	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	22.32	1.67	5.33	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	20.51	0.00	6.03	2.41	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	2.13	1.42	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.25	2.75	4.81	1.72	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	21.47	1.07	4.29	1.07	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	18.85	1.35	4.04	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.52	1.85	2.22	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	2.33	5.81	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	23.27	0.00	0.00	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	16.81	2.80	6.40	0.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	25.44	2.18	7.27	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	26.83	0.77	5.37	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.73	0.49	5.92	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	23.52	0.00	4.70	3.76	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	21.62	4.02	4.02	2.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	21.18	2.25	5.86	1.35	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	25.82	0.00	1.72	6.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	28.50	1.78	5.79	0.45	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	18.77	3.13	5.47	1.56	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.79	1.32	5.28	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	23.87	1.56	9.34	2.08	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	20.13	2.63	4.38	2.63	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	21.25	1.68	3.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.97	1.32	5.74	0.44	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.53	1.16	6.56	1.93	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	19.24	2.03	5.57	3.54	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	20.67	2.88	7.21	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	16.30	1.99	3.98	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	21.87	1.82	5.47	1.82	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	10.38	1.38	4.15	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	17.48	4.56	4.18	1.14	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.59	1.55	8.78	2.07	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.09	0.00	4.84	1.21	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	22.82	2.85	7.29	0.63	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.79	2.13	6.40	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.64	0.57	4.02	0.57	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	16.97	1.54	6.69	1.03	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	17.68	2.83	7.78	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	15.32	0.57	6.81	2.27	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	17.47	1.66	7.49	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	0.78	3.13	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	15.45	0.84	2.51	0.84	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	21.84	1.86	6.97	1.86	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.73	2.01	4.01	1.34	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	12.83	1.07	7.48	0.00	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	23.44	0.81	6.87	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	16.52	0.00	12.85	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	12.45	0.89	5.33	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.81	3.42	5.70	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.17	0.77	7.67	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	18.06	0.00	6.57	1.64	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	20.05	2.23	9.80	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	21.06	2.34	5.72	0.78	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	20.56	0.66	7.29	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	0.00	6.24	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	19.83	2.73	2.05	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	17.43	2.02	1.65	0.37	0.18
Macrophage - monocyte derived, donor3	11389-118C3	19.66	4.33	1.70	0.13	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	23.90	0.53	3.72	3.72	2.66
Mallassez-derived cells, donor2	11929-125I3	62.11	5.70	5.23	2.38	3.01
Mallassez-derived cells, donor3	11930-125I4	66.85	3.34	5.42	4.31	3.06
Mammary Epithelial Cell, donor1	11273-116H4	38.56	5.88	5.98	6.88	2.89
Mammary Epithelial Cell, donor2	11350-117G9	49.80	2.90	5.21	5.21	4.34
Mammary Epithelial Cell, donor3	11422-118F9	22.20	3.24	2.99	1.50	1.00
Mast cell - stimulated, donor1	11487-119E2	39.32	4.75	2.71	0.00	1.36
Mast cell, donor1	11563-120D6	41.20	9.95	2.70	1.62	1.41
Mast cell, donor2	11565-120D8	57.35	9.21	5.94	2.67	0.59
Mast cell, donor3	11566-120D9	59.66	13.51	6.75	0.90	1.35
Mast cell, donor4	11567-120E1	57.80	17.37	6.91	1.24	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	60.44	6.65	4.55	2.22	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	25.10	4.67	4.67	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	58.74	5.97	6.77	1.61	1.26
Mast cell, expanded, donor8	11941-126A6	58.24	9.71	3.01	3.18	2.51
Melanocyte - dark, donor1	11502-119F8	40.99	5.87	3.48	0.70	0.60
Melanocyte - dark, donor2	11582-120F7	22.15	1.38	2.42	1.38	1.04
Melanocyte - dark, donor3	11663-122F7	59.55	5.36	3.77	9.92	3.91
Melanocyte - light, donor1	11274-116H5	13.87	1.88	0.24	2.12	1.65
Melanocyte - light, donor2	11351-117H1	10.24	1.36	0.00	0.68	1.36
Melanocyte - light, donor3	11423-118G1	15.61	1.73	0.00	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	56.02	3.44	1.87	3.02	1.67
Melanocyte, donor2 (MC+2)	12739-135I3	31.20	1.61	1.34	7.26	3.23
Melanocyte, donor3 (MC+3)	12837-137B2	28.66	3.21	1.61	2.95	1.34
Meningeal Cells, donor1	11493-119E8	69.10	2.11	9.30	6.45	2.61
Meningeal Cells, donor2	11573-120E7	59.42	5.28	7.48	7.48	4.40
Meningeal Cells, donor3	11654-122E7	78.89	2.85	8.97	4.65	1.55
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	71.00	6.56	6.84	2.57	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.60	3.32	1.01	1.01	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	3.94	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	2.62	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	45.21	3.59	2.15	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	31.34	2.54	2.12	1.91	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	28.15	2.51	1.01	2.01	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	30.55	1.98	6.15	1.76	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	33.61	2.19	8.77	2.19	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	20.46	1.64	4.30	1.84	1.64
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	29.09	4.99	2.08	2.35	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.95	1.12	0.37	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	33.95	3.68	1.32	1.32	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.09	1.78	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	27.54	2.56	1.92	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	58.84	3.90	6.38	0.71	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	37.21	4.38	0.63	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	49.35	3.63	5.08	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	20.95	2.39	1.33	1.33	0.53
Mesothelial Cells, donor2	12156-128G5	16.01	2.00	0.00	2.00	1.50
Mesothelial Cells, donor3	11402-118D7	14.96	3.18	1.52	1.59	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	13.50	2.70	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	15.02	1.72	1.48	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.37	1.47	3.24	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.40	1.86	1.24	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.54	1.45	2.07	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.77	1.25	1.50	0.00	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	10.71	0.93	2.33	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	12.80	2.03	1.42	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.90	0.79	1.58	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	12.39	0.88	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.64	0.76	1.90	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	11.04	1.49	1.27	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.54	2.09	1.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	1.68	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	9.53	1.00	1.76	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.74	0.95	0.95	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.98	0.00	0.55	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.06	0.92	1.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.57	0.63	1.47	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.13	0.82	1.22	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.94	0.64	1.07	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.56	1.11	1.33	0.22	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.45	0.88	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.08	1.01	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.43	0.54	0.82	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.47	1.18	2.06	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	1.09	2.18	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	0.48	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	7.20	1.20	1.60	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	0.00	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.01	1.50	1.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.07	1.31	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	0.64	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.17	0.00	1.49	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	0.70	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.55	0.00	1.03	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.81	0.00	2.63	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.17	0.71	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.91	1.12	0.84	0.00	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	10.39	0.83	3.74	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.08	0.58	1.17	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.78	0.60	1.21	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	11.27	0.83	2.50	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	7.39	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	10.81	1.14	1.71	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	9.40	1.11	1.52	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.70	1.55	1.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.86	0.86	0.00	1.29	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.34	1.60	1.33	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.77	0.90	2.39	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.48	1.98	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.15	0.00	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	10.61	1.77	2.21	0.22	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.86	1.14	2.28	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.63	1.42	1.99	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.57	1.23	1.23	0.25	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	8.47	1.30	0.00	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.29	0.29	2.35	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	15.86	0.86	0.86	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.43	2.47	0.82	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.89	0.30	0.60	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	5.35	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	17.74	2.63	2.30	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	14.73	4.21	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	20.16	3.16	1.58	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	16.76	1.86	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.89	3.76	0.75	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	14.12	2.93	1.07	0.80	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.83	1.58	1.02	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	2.21	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	18.32	1.83	0.73	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	26.45	1.56	1.56	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	11.76	1.07	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	3.03	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.43	2.11	1.26	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	0.00	0.00	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	0.00	3.26	9.79	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	43.09	2.37	3.02	1.08	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	33.97	2.61	2.09	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.69	2.00	1.33	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	14.61	2.09	2.09	1.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	61.42	3.61	4.75	1.90	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	65.43	4.79	6.38	4.79	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	1.36	2.04	2.72	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	124.96	1.84	12.86	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.39	4.19	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	18.83	4.88	3.95	2.56	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.75	2.70	1.35	2.16	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	22.29	2.31	2.52	1.47	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	189.29	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.39	1.99	0.00	1.49	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.41	2.98	1.62	2.44	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.37	3.40	0.91	2.04	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.57	2.45	0.98	2.12	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.79	2.73	1.64	2.00	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.26	0.53	0.53	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	1.80	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	46.60	2.63	0.33	2.30	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.22	2.93	0.65	1.95	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	30.16	3.35	2.47	2.82	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	13.36	2.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.19	3.68	0.46	1.84	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	13.18	3.86	0.32	0.96	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	45.87	1.72	1.72	3.79	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	144.12	7.59	5.06	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.61	3.56	1.11	2.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.58	1.69	1.69	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.56	1.66	0.47	2.61	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	14.17	2.58	1.72	3.43	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	171.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	13.33	2.33	1.33	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	15.33	2.71	0.45	1.35	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	12.70	1.98	0.40	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	15.79	2.79	0.00	2.79	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	24.97	3.41	0.00	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	11.73	2.61	0.98	1.96	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	4.36	3.05	0.44	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	27.59	5.43	2.26	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	0.88	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.30	1.33	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	13.39	2.48	0.99	1.49	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.89	3.83	0.00	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	36.90	2.12	0.00	0.60	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	21.44	2.21	0.88	0.00	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	91.97	0.00	5.11	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.97	2.44	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.65	2.83	1.26	0.94	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.90	2.12	0.91	0.91	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	19.78	3.16	0.00	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	43.08	5.67	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	182.08	0.00	10.12	0.00	10.12
Myoblast, donor1	11241-116D8	36.27	2.11	3.85	1.12	1.24
Myoblast, donor2	11322-117D8	27.81	2.49	2.30	1.73	1.15
Myoblast, donor3	11398-118D3	37.16	4.04	4.04	2.86	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	82.45	7.59	2.19	1.75	2.92
Natural Killer Cells, donor1	11230-116C6	79.65	9.23	2.15	2.15	4.61
Natural Killer Cells, donor2	11311-117C6	61.82	9.35	2.71	0.60	3.02
Natural Killer Cells, donor3	11387-118C1	64.79	10.12	2.76	1.47	3.50
Neural stem cells, donor1	11275-116H6	96.90	3.63	10.89	5.44	1.81
Neural stem cells, donor2	11352-117H2	107.84	3.85	5.78	3.85	1.93
Neurons, donor1	11494-119E9	93.31	1.14	7.97	1.14	1.14
Neurons, donor2	11574-120E8	102.38	3.08	4.62	1.98	3.08
Neurons, donor3	11655-122E8	116.75	0.82	1.64	4.11	0.82
Neutrophils, donor1	11233-116C9	23.20	3.71	4.64	0.00	0.00
Neutrophils, donor2	11314-117C9	23.19	2.90	5.80	0.00	2.90
Neutrophils, donor3	11390-118C4	25.04	4.28	5.50	0.61	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	47.85	5.94	1.19	4.87	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	18.88	6.51	1.95	5.21	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	23.46	3.21	1.60	2.41	0.80
Olfactory epithelial cells, donor1	11933-125I7	22.30	4.82	0.69	2.20	0.55
Olfactory epithelial cells, donor2	11934-125I8	25.19	5.36	1.45	2.32	0.58
Olfactory epithelial cells, donor3	11935-125I9	20.54	4.09	0.45	1.48	0.79
Olfactory epithelial cells, donor4	11936-126A1	28.15	4.09	1.07	1.27	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	31.29	1.81	1.81	4.81	3.01
Osteoblast - differentiated, donor1	11276-116H7	19.99	2.55	0.85	0.85	1.06
Osteoblast - differentiated, donor2	11353-117H3	9.14	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.17	8.07	0.62	1.24	0.00
Osteoblast, donor1	11277-116H8	27.36	1.76	3.91	1.17	0.59
Osteoblast, donor2	11354-117H4	51.27	4.92	2.11	0.70	2.11
Osteoblast, donor3	11426-118G4	36.26	3.91	5.69	1.60	1.24
Pancreatic stromal cells, donor1	11249-116E7	53.49	4.55	4.30	1.01	1.35
Pericytes, donor1	11491-119E6	16.58	2.11	3.12	8.34	5.90
Pericytes, donor2	11571-120E5	19.92	2.26	2.49	5.21	4.07
Pericytes, donor3	11652-122E5	19.33	3.26	2.03	1.22	0.00
Perineurial Cells, donor1	11499-119F5	47.81	4.97	4.18	1.70	0.79
Perineurial Cells, donor2	11579-120F4	31.74	2.58	2.48	1.10	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	72.99	8.29	2.87	0.64	3.51
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	45.79	3.92	1.96	0.00	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	59.27	8.02	2.72	0.78	3.11
Placental Epithelial Cells, donor1	11278-116H9	21.76	1.43	2.39	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	23.29	3.33	2.22	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	26.11	3.34	3.73	2.36	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	14.24	1.90	0.32	0.95	0.32
Preadipocyte - breast, donor1	11467-119B9	27.95	2.81	0.94	0.19	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	40.46	1.04	0.91	0.52	0.91
Preadipocyte - breast, donor2	11328-117E5	31.07	2.03	0.68	1.58	1.35
Preadipocyte - omental, donor1	11468-119C1	23.87	2.24	0.64	0.96	0.75
Preadipocyte - omental, donor2	11329-117E6	40.16	5.24	0.87	0.44	1.31
Preadipocyte - omental, donor3	11403-118D8	25.64	3.58	1.15	0.72	1.15
Preadipocyte - perirenal, donor1	11469-119C2	13.78	1.97	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	13.51	1.84	2.15	1.54	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	51.35	6.73	8.85	2.12	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	30.65	4.26	2.72	1.53	0.68
Preadipocyte - visceral, donor1	11280-116I2	48.16	8.29	5.31	2.05	0.65
Preadipocyte - visceral, donor2	11357-117H7	31.75	3.68	1.84	2.30	0.46
Preadipocyte - visceral, donor3	11429-118G7	36.36	3.66	4.70	2.93	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	76.63	2.56	5.28	5.43	6.49
Prostate Epithelial Cells, donor2	11331-117E8	30.33	5.01	4.33	5.42	2.03
Prostate Epithelial Cells, donor3	11404-118D9	25.96	7.53	1.53	3.12	0.86
Prostate Stromal Cells, donor1	11254-116F3	53.99	4.56	4.33	1.48	0.80
Prostate Stromal Cells, donor2	11332-117E9	46.44	2.87	4.84	0.90	0.90
Prostate Stromal Cells, donor3	11405-118E1	23.57	5.11	1.56	1.67	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.15	4.38	2.92	3.65	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	49.70	3.40	5.13	2.63	1.32
Renal Epithelial Cells, donor1	11517-119H5	10.14	2.54	1.01	5.07	0.51
Renal Epithelial Cells, donor2	11597-120H4	21.34	3.56	6.40	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	57.91	4.76	8.15	4.55	2.01
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.81	2.72	2.04	2.04	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	26.28	3.50	6.06	1.62	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	42.40	2.00	6.22	2.44	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	2.00	0.67	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	21.79	3.96	4.84	3.52	1.32
Renal Mesangial Cells, donor2	11598-120H5	30.72	1.25	2.51	6.27	0.00
Renal Mesangial Cells, donor3	11679-122H5	13.04	0.83	1.39	1.94	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	52.07	3.22	8.05	4.56	2.15
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	23.19	2.95	3.37	2.95	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	33.17	3.09	3.47	5.59	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	76.75	4.93	5.70	1.04	3.11
Retinal Pigment Epithelial Cells, donor1	11528-119I7	47.75	4.55	3.41	3.13	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	19.55	1.03	4.12	2.06	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	39.64	1.25	1.51	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	50.38	7.88	2.81	1.87	2.41
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	51.82	2.68	1.79	2.68	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	84.21	0.55	1.10	1.65	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	77.15	1.16	0.58	1.74	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	55.91	0.39	5.33	1.30	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	51.04	0.50	3.57	1.89	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	62.68	1.56	4.24	1.45	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	67.60	1.61	6.20	1.36	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	55.13	1.75	3.15	0.82	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	61.71	1.39	5.32	1.39	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	41.35	0.41	5.34	0.96	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	54.46	1.21	5.60	1.36	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	56.80	2.69	4.84	1.08	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	35.43	1.00	5.45	1.43	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	54.73	0.86	3.86	1.18	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	51.11	1.99	3.10	3.54	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	38.24	0.76	4.21	0.76	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	57.57	1.02	3.73	1.96	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	66.71	1.32	4.51	2.44	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	38.22	0.53	5.44	1.06	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	55.10	1.36	4.48	1.85	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	59.39	1.15	4.77	1.53	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	37.48	0.32	4.70	1.17	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	45.69	0.28	3.64	0.56	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	50.76	0.85	4.44	1.20	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.92	0.91	5.11	1.82	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	48.19	0.98	4.91	0.86	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	56.01	1.75	2.96	1.48	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	38.45	0.71	8.49	2.59	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	46.83	1.79	3.57	1.59	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	63.14	1.40	3.51	2.10	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	42.92	1.04	5.81	0.41	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	52.65	0.44	5.53	0.66	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	48.25	1.04	5.01	1.25	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	41.72	0.67	6.59	1.88	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	51.77	1.36	4.26	2.04	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	51.67	1.16	3.66	0.96	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	47.28	0.34	8.25	2.92	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	47.19	1.78	6.86	2.47	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	65.18	1.15	3.61	2.63	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	39.37	1.02	4.60	1.19	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	56.22	2.22	3.26	1.33	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	42.91	1.60	3.47	1.60	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	32.77	0.55	1.80	0.97	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	53.33	0.71	2.62	1.67	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	49.18	0.60	4.03	2.22	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	34.75	0.19	2.17	1.13	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	45.42	1.75	2.10	2.79	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	46.84	1.21	3.32	2.72	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	43.94	0.73	3.18	3.79	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	91.26	1.75	2.77	2.91	3.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	45.63	1.83	1.83	1.83	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	41.29	0.90	3.01	2.71	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.24	0.45	2.26	1.81	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	55.41	1.20	1.50	4.49	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	43.45	0.83	1.89	1.30	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	50.59	1.71	1.92	2.13	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	56.49	1.80	2.40	2.40	1.80
Schwann Cells, donor1	11498-119F4	17.68	0.94	2.26	2.07	0.38
Schwann Cells, donor2	11578-120F3	44.23	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	36.59	3.51	4.16	3.94	0.88
Sebocyte, donor1	11220-116B5	48.75	2.19	3.29	2.74	1.64
Sebocyte, donor2	11301-117B5	24.82	2.30	0.46	0.46	1.84
Sebocyte, donor3	11378-118B1	22.26	4.12	1.65	1.24	1.03
Sertoli Cells, donor1	11255-116F4	38.10	1.66	1.66	3.31	1.66
Sertoli Cells, donor2	11333-117F1	33.89	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	29.65	1.94	1.23	0.70	0.53
Skeletal Muscle Cells, donor2	11358-117H8	9.40	1.45	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	24.25	0.00	3.34	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	42.89	3.46	5.34	1.89	0.79
Skeletal Muscle Cells, donor5	11455-119A6	39.24	5.20	3.86	1.49	0.45
Skeletal Muscle Cells, donor6	11459-119B1	50.63	3.69	5.39	0.92	1.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	48.13	4.16	2.77	2.02	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	38.53	5.71	4.00	1.57	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	62.01	5.46	5.65	2.38	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	35.47	2.02	2.78	1.60	1.26
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.99	2.90	2.17	2.90	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	17.75	0.83	1.79	1.79	0.83
Skin - palm, donor1	10286-104F7	34.92	0.00	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.44	2.02	2.74	1.87	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	63.80	0.00	7.36	4.91	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.60	2.08	3.64	2.60	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	30.30	4.45	4.31	5.70	2.09
Small Airway Epithelial Cells, donor2	11334-117F2	19.41	4.36	2.39	3.38	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	78.45	6.55	7.61	4.02	3.81
Small Airway Epithelial Cells, donor3	11406-118E2	19.56	7.64	2.92	3.82	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	19.13	2.78	2.47	0.00	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.01	3.11	2.45	0.00	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	26.45	4.11	2.35	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	22.76	2.65	2.65	0.66	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.08	2.76	2.76	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	26.27	5.41	5.41	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	25.02	1.00	1.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	26.22	2.66	2.40	1.60	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	21.28	4.21	3.10	1.11	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	35.08	3.84	3.71	3.33	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	47.21	3.26	7.49	3.58	2.93
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	35.14	6.50	3.84	2.36	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.06	3.70	1.71	1.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	14.48	2.28	0.98	0.65	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.92	2.44	2.44	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.69	3.28	1.77	0.00	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	11.44	0.95	1.43	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	32.74	1.62	2.80	1.77	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	30.13	2.37	2.15	1.72	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	34.53	2.94	2.94	1.68	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.44	4.02	1.24	1.08	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	23.71	3.23	1.08	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	25.70	2.39	3.29	1.49	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	14.34	3.07	2.39	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	36.91	3.22	0.71	0.55	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	27.98	5.33	2.11	0.50	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	22.30	3.64	2.96	0.68	2.73
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.30	0.00	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	75.24	2.38	11.13	2.12	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	30.89	2.66	4.13	1.86	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	22.41	2.75	2.00	1.50	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.84	2.54	1.01	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	45.23	4.07	4.67	1.51	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	17.25	5.25	0.75	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	41.35	1.29	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.04	4.19	1.86	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	20.70	1.01	2.02	1.01	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.97	1.25	3.13	0.94	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	11.50	4.42	1.18	1.77	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	58.73	6.50	11.91	2.92	0.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	26.63	3.74	2.34	1.87	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	27.63	5.04	2.01	2.16	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	27.54	2.55	2.29	0.76	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	20.68	1.13	3.57	1.13	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	51.15	5.31	5.31	1.40	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.99	3.94	1.34	0.34	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.67	1.43	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.49	6.85	3.43	0.98	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	16.35	2.65	1.10	1.33	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	32.18	1.76	2.93	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	21.96	3.11	1.17	0.58	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.18	0.53	1.06	0.79	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	46.87	1.12	1.86	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	31.62	1.80	2.52	1.08	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	21.29	1.42	1.42	1.14	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	65.38	1.58	5.51	2.76	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	26.66	1.27	0.76	1.02	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	23.96	3.99	1.60	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	21.74	2.51	0.00	2.09	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	22.92	1.83	1.38	1.38	0.46
Synoviocyte, donor1	11291-117A4	25.92	3.87	1.01	0.84	0.50
Synoviocyte, donor2	11368-117I9	20.79	3.86	1.34	0.67	0.84
Synoviocyte, donor3	11440-118H9	21.89	2.90	1.34	1.12	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	31.09	3.22	4.29	2.50	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	11.35	1.62	1.62	1.16	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	32.83	2.94	4.30	2.80	1.29
Tracheal Epithelial Cells, donor2	11369-118A1	14.30	1.55	2.71	0.39	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	12.03	0.00	2.86	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	49.33	6.77	3.20	2.83	2.34
Urethra, donor2	10319-105A4	43.16	1.80	1.80	3.60	0.00
Urothelial Cells, donor1	11520-119H8	17.80	2.13	2.39	1.33	1.86
Urothelial Cells, donor2	11600-120H7	12.42	4.41	2.00	2.40	0.00
Urothelial Cells, donor3	11681-122H7	9.17	3.21	0.69	1.38	0.00
Urothelial cells, donor0	11216-116B1	37.45	10.03	2.45	2.23	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	58.73	17.80	8.01	1.78	9.79
Whole blood (ribopure), donor090309, donation2	12180-129A2	81.49	40.03	8.58	11.44	17.16
Whole blood (ribopure), donor090309, donation3	12181-129A3	41.76	21.90	5.48	2.05	4.79
Whole blood (ribopure), donor090325, donation1	12176-128I7	63.70	18.25	4.13	1.72	7.92
Whole blood (ribopure), donor090325, donation2	12177-128I8	68.56	22.08	6.97	1.74	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	53.10	23.95	5.21	1.04	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	83.52	27.53	11.01	0.00	6.42
Whole blood (ribopure), donor090612, donation3	12184-129A6	60.25	24.65	2.74	2.74	7.30
Wilms' tumor cell line:G-401	10809-111A8	64.27	6.17	6.91	2.84	3.21
Wilms' tumor cell line:HFWT	10597-108E3	43.12	3.52	6.16	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.36	1.96	3.35	3.35	0.28
achilles tendon, donor2	10292-104G4	18.60	0.00	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	67.56	1.53	2.55	2.29	3.57
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	103.09	5.80	6.04	5.80	3.25
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	112.30	2.37	7.00	0.59	4.04
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	96.06	6.26	9.52	1.09	7.07
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	86.29	2.53	9.56	0.28	2.25
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	68.10	5.08	4.02	1.69	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	26.13	1.36	1.63	1.09	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	57.72	4.41	4.85	2.20	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	77.59	6.13	6.13	0.82	3.27
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	73.78	6.21	4.66	2.72	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	76.36	4.23	6.26	1.29	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	15.60	11.70	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	89.47	5.11	5.58	2.09	3.72
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	93.98	3.62	4.92	0.26	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	83.00	6.72	8.48	0.29	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	40.90	5.11	6.97	1.39	2.79
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	67.45	3.29	2.06	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	12.89	7.67	8.59	0.92	1.53
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	67.85	8.96	14.51	0.43	4.27
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	62.78	6.98	9.71	1.82	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	76.30	8.91	11.31	0.48	2.41
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	55.46	2.23	5.79	0.45	1.78
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	74.05	2.33	9.67	0.33	2.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	163.52	11.15	16.72	11.15	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	75.33	1.51	10.17	0.00	5.27
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	69.35	5.67	3.93	3.49	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	58.11	11.25	7.50	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	36.74	8.48	1.18	3.06	3.06
adipose tissue, adult, pool1	10010-101C1	50.88	4.34	2.17	0.47	0.16
adipose, donor1	10184-103D4	202.31	2.93	8.21	0.59	1.76
adipose, donor2	10185-103D5	32.44	5.68	6.89	0.81	0.41
adipose, donor3	10186-103D6	59.09	3.54	5.17	4.08	1.09
adipose, donor4	10187-103D7	69.34	3.47	4.33	4.33	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	41.51	9.63	13.10	1.89	0.79
adrenal gland, adult, pool1	10081-102A9	29.10	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	54.56	4.54	2.67	0.53	1.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	63.96	7.86	4.29	1.43	1.43
amniotic membrane cells, donor1	12235-129G3	48.22	19.01	4.41	3.48	2.55
amniotic membrane cells, donor2	12236-129G4	52.74	10.48	5.75	3.04	1.35
amniotic membrane cells, donor3	12237-129G5	50.08	10.31	5.01	2.06	1.47
amygdala - adult, donor10196	10167-103B5	75.89	5.93	4.74	2.37	3.56
amygdala, adult, donor10252	10151-102I7	75.63	10.34	5.07	3.45	3.24
amygdala, newborn, donor10223	10360-105E9	50.67	1.61	2.58	0.97	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	39.60	2.29	0.89	0.38	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	36.62	4.63	3.75	0.66	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	100.88	5.01	4.68	6.35	1.67
aorta, adult, pool1	10052-101G7	41.97	4.12	1.37	0.78	0.39
appendix, adult	10189-103D9	66.37	4.66	5.82	1.16	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	66.38	6.53	3.10	5.16	3.10
artery, adult	10190-103E1	55.71	4.08	2.72	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	53.02	6.37	3.77	2.32	0.58
b cell line:RPMI1788	10427-106D4	61.12	6.54	4.46	1.34	1.93
basal cell carcinoma cell line:TE 354.T	10702-109G9	44.11	4.72	1.94	0.83	2.77
bile duct carcinoma cell line:HuCCT1	10432-106D9	41.68	5.66	6.05	0.89	1.49
bile duct carcinoma cell line:TFK-1	10496-107C1	28.79	2.68	2.85	2.18	1.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	24.61	2.24	2.80	0.56	0.56
bladder, adult, pool1	10011-101C2	58.56	3.37	1.30	0.98	1.30
blood, adult, pool1	10053-101G8	35.43	35.43	2.21	4.43	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	41.10	2.57	2.57	1.71	0.00
bone marrow, adult	10192-103E3	48.59	3.37	0.67	0.00	1.35
brain, adult, donor1	10084-102B3	52.28	5.13	6.15	5.13	1.03
brain, adult, pool1	10012-101C3	73.27	6.12	2.56	1.89	2.56
brain, fetal, pool1	10085-102B4	48.09	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	47.90	2.97	4.29	1.65	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	54.80	11.23	5.74	12.73	5.12
breast, adult, donor1	10080-102A8	27.15	3.79	2.53	1.26	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	59.96	10.93	9.91	12.58	3.30
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	27.52	7.11	9.28	7.42	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	57.32	2.07	5.99	0.69	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.74	3.39	2.42	3.87	0.73
carcinoid cell line:NCI-H1770	10703-109H1	97.79	1.88	6.11	1.41	2.35
carcinoid cell line:NCI-H727	10735-110B6	52.07	5.47	2.84	5.58	3.17
carcinoid cell line:SK-PN-DW	10719-109I8	37.08	1.27	0.32	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	91.30	3.99	15.44	14.91	1.60
caudate nucleus - adult, donor10196	10177-103C6	92.11	2.30	4.61	3.45	1.15
caudate nucleus, adult, donor10252	10164-103B2	84.50	10.04	4.69	5.35	5.69
caudate nucleus, adult, donor10258	10379-105H1	79.47	3.82	0.76	7.64	3.06
caudate nucleus, newborn, donor10223	10354-105E3	59.70	3.30	1.46	0.73	1.46
cerebellum - adult, donor10196	10173-103C2	107.79	5.83	5.83	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	140.28	3.84	5.98	1.92	4.70
cerebellum, adult, pool1	10083-102B2	62.44	3.79	2.76	0.34	1.38
cerebellum, newborn, donor10223	10357-105E6	137.00	0.00	4.15	1.66	2.49
cerebral meninges, adult	10188-103D8	57.24	10.09	4.03	3.03	1.76
cerebrospinal fluid, donor2	10294-104G6	36.54	4.39	3.65	0.73	1.46
cervical cancer cell line:D98-AH2	10552-107I3	96.05	5.90	4.31	6.47	3.59
cervical cancer cell line:ME-180	10553-107I4	49.22	7.79	8.29	7.29	2.98
cervix, adult, pool1	10013-101C4	69.50	2.83	1.47	1.78	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	56.15	4.18	2.37	0.14	1.81
chondrosarcoma cell line:SW 1353	10700-109G7	37.88	2.61	7.84	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	58.78	3.73	4.72	1.74	1.62
choriocarcinoma cell line:SCH	10785-110H2	31.30	3.82	5.54	1.97	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	27.04	3.08	5.46	2.37	0.47
chorionic membrane cells, donor1	12238-129G6	29.06	7.12	1.71	1.71	1.14
chorionic membrane cells, donor2	12239-129G7	46.83	2.88	2.19	2.39	1.09
chorionic membrane cells, donor3	12240-129G8	30.77	8.79	2.20	2.20	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	52.51	0.00	4.04	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	68.77	6.34	5.76	2.31	4.80
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	87.01	14.99	8.45	5.07	1.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	73.19	4.37	7.19	3.60	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	72.08	3.39	7.74	2.90	2.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	68.82	5.09	6.72	2.85	2.65
chronic myelogenous leukemia cell line:K562	10454-106G4	101.59	6.77	4.71	5.89	4.12
chronic myelogenous leukemia cell line:KU812	10409-106B4	105.29	9.38	11.99	2.09	2.09
clear cell carcinoma cell line:JHOC-5	10638-108I8	48.00	3.89	3.43	1.37	0.23
clear cell carcinoma cell line:TEN	10636-108I6	62.81	3.47	6.07	4.68	3.12
colon carcinoma cell line:CACO-2	10513-107D9	73.22	5.31	8.05	9.15	4.76
colon carcinoma cell line:COLO-320	10420-106C6	114.78	3.42	1.14	1.90	2.28
colon, adult, donor1	10082-102B1	33.32	4.76	0.00	5.95	0.00
colon, adult, pool1	10014-101C5	52.17	4.47	1.18	4.11	1.41
colon, fetal, donor1	10070-101I7	28.43	4.33	1.24	3.71	1.85
common myeloid progenitor CMP, donor1	12130-128D6	142.09	9.17	13.75	9.17	13.75
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	64.16	2.97	8.50	5.10	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	65.81	4.23	4.98	5.13	3.32
cord blood derived cell line:COBL-a untreated	10449-106F8	75.58	2.68	5.64	7.19	4.09
corpus callosum, adult, pool1	10042-101F6	120.18	9.95	10.84	2.99	5.97
cruciate ligament, donor2	10295-104G7	38.09	4.05	1.62	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	51.36	0.80	1.61	4.01	0.80
diencephalon, adult	10193-103E4	67.20	6.24	5.28	3.36	4.08
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	94.14	4.36	6.20	2.07	3.67
ductal cell carcinoma cell line:KLM-1	10438-106E6	25.90	3.33	3.59	1.80	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	33.46	4.09	5.30	3.85	2.65
ductus deferens, adult	10196-103E7	50.33	7.48	0.50	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	1.44	1.44	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	68.42	2.21	3.68	0.00	0.74
dura mater, adult, donor1	10041-101F5	32.62	6.94	1.98	0.66	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	57.96	2.89	6.00	4.44	2.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	81.25	0.57	15.62	0.14	2.29
embryonic pancreas cell line:1B2C6	10604-108F1	45.01	3.70	3.70	3.08	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	30.57	5.75	3.33	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	35.81	5.56	2.78	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	55.17	6.57	3.94	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	24.80	3.69	2.01	2.35	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	47.48	3.99	2.54	0.91	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	39.40	5.79	4.02	5.47	1.45
epidermoid carcinoma cell line:A431	10426-106D3	63.47	5.56	7.67	6.78	5.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	49.49	5.83	7.81	4.29	3.08
epididymis, adult	10197-103E8	43.12	3.77	3.98	4.40	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	58.37	6.03	4.44	0.53	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	20.84	3.15	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	77.84	7.47	10.09	10.75	6.03
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	79.13	7.48	7.78	14.37	6.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	77.75	9.19	10.08	11.31	6.95
esophagus, adult, pool1	10015-101C6	58.50	4.78	4.14	2.76	2.44
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	52.85	5.13	2.00	0.63	0.38
eye - muscle inferior rectus, donor1	10272-104E2	43.46	9.66	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	48.40	0.00	2.10	6.31	0.00
eye - muscle medial, donor2	10299-104H2	49.11	1.49	1.49	4.46	1.49
eye - muscle superior, donor2	10297-104G9	40.13	0.00	2.29	6.88	1.15
eye - vitreous humor, donor1	10268-104D7	29.15	1.46	4.37	1.46	1.46
eye, fetal, donor1	10054-101G9	61.78	5.08	2.80	2.03	4.07
fibrosarcoma cell line:HT-1080	10758-110E2	35.65	4.87	2.56	1.15	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	75.74	8.31	8.31	3.09	2.14
frontal lobe, adult, pool1	10040-101F4	85.00	7.88	3.85	3.19	4.41
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	88.87	6.91	10.81	10.51	3.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	39.13	3.11	3.20	0.09	0.27
gall bladder, adult	10198-103E9	36.94	4.83	2.41	1.69	1.45
gamma delta positive T cells, donor1	11937-126A2	77.84	7.52	1.61	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	70.96	7.10	1.87	1.12	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	69.91	2.96	4.65	4.86	4.22
gastric adenocarcinoma cell line:MKN45	10612-108F9	32.88	5.42	2.71	1.35	0.77
gastric cancer cell line:AZ521	10549-107H9	70.66	4.75	5.25	5.25	2.62
gastric cancer cell line:GSS	10560-108A2	31.12	7.32	3.66	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	64.65	1.83	2.51	0.00	2.74
giant cell carcinoma cell line:LU65	10487-107B1	31.44	1.72	1.84	1.15	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	34.99	3.78	3.08	0.56	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	37.16	3.24	8.98	8.48	4.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	67.87	3.59	3.69	4.33	2.43
glioblastoma cell line:A172, tech_rep2	10444-106F3	66.15	3.65	4.92	6.46	2.25
glioblastoma cell line:T98G	10485-107A8	69.98	4.53	3.31	3.75	1.99
glioma cell line:GI-1	10413-106B8	33.39	3.51	1.17	1.46	1.17
globus pallidus - adult, donor10196	10175-103C4	68.52	7.29	6.56	3.64	5.83
globus pallidus, adult, donor10252	10161-103A8	112.77	11.47	12.45	6.10	6.83
globus pallidus, adult, donor10258	10367-105F7	82.15	4.11	2.74	2.74	2.74
globus pallidus, newborn, donor10223	10364-105F4	43.70	2.66	2.13	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	115.02	17.13	29.37	7.34	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	33.92	4.16	3.20	1.28	0.64
hIPS +CCl2, biol_rep1	14383-156B9	62.90	3.21	13.77	4.59	0.00
hIPS +CCl2, biol_rep2	14384-156C1	63.56	0.91	10.52	3.20	3.20
hIPS +CCl2, biol_rep3	14385-156C2	70.85	0.64	10.31	4.51	3.22
hIPS, biol_rep1	14380-156B6	79.05	0.00	31.62	4.31	1.44
hIPS, biol_rep2	14381-156B7	66.53	0.69	13.03	5.49	0.69
hIPS, biol_rep3	14382-156B8	71.73	5.52	2.21	3.31	3.31
hairy cell leukemia cell line:Mo	10712-109I1	51.72	2.87	6.32	5.17	2.30
heart - mitral valve, adult	10205-103F7	61.29	7.77	4.19	0.90	1.20
heart - pulmonic valve, adult	10206-103F8	74.52	3.66	3.14	2.61	0.78
heart - tricuspid valve, adult	10207-103F9	40.80	5.00	1.67	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	54.48	8.77	3.88	3.47	1.22
heart, adult, diseased, donor1	10051-101G6	60.89	10.65	2.13	8.94	1.70
heart, adult, pool1	10016-101C7	60.48	9.20	2.53	6.21	1.84
heart, fetal, pool1	10046-101G1	126.50	5.24	3.29	10.99	2.88
hepatic mesenchymal tumor cell line:LI90	10778-110G4	23.45	6.17	0.62	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	82.05	3.57	5.95	1.19	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	73.37	4.86	6.30	6.41	5.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	79.01	3.88	7.77	5.83	5.83
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	73.47	3.74	6.37	6.77	4.65
hepatoma cell line:Li-7	10484-107A7	49.16	1.00	3.23	1.78	1.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	60.40	3.52	7.94	1.81	1.71
hippocampus - adult, donor10196	10169-103B7	51.10	2.84	1.89	3.79	3.79
hippocampus, adult, donor10252	10153-102I9	85.72	10.20	6.94	4.69	6.94
hippocampus, adult, donor10258	10374-105G5	77.68	2.99	4.48	2.49	1.49
hippocampus, newborn, donor10223	10363-105F3	35.95	2.47	1.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	210.57	1.83	18.92	4.27	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	77.56	2.95	11.00	5.30	2.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	88.61	2.79	12.95	3.55	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	65.41	0.00	6.20	1.13	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	68.43	1.29	4.39	1.29	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	86.17	0.76	6.07	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	93.43	1.75	10.51	2.04	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	62.26	3.88	8.19	2.15	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	55.47	2.09	11.26	3.75	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	89.98	2.13	10.42	3.08	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	86.47	1.29	6.59	5.30	2.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	93.59	2.02	8.08	4.04	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	66.35	3.44	10.80	3.29	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	83.03	4.42	11.30	7.37	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	161.46	1.75	9.60	6.98	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	66.63	1.91	4.20	0.00	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	68.03	1.31	5.23	0.44	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	107.95	1.00	6.00	0.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	49.55	2.83	5.65	1.70	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	50.93	4.09	6.37	3.18	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	56.38	2.51	8.14	1.25	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	67.61	3.92	7.19	3.43	1.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	66.77	4.94	6.10	2.90	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	75.63	3.59	5.38	4.18	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	67.99	2.96	13.30	4.25	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	65.04	1.14	11.13	7.13	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	135.97	4.49	20.01	6.94	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	82.39	2.11	7.75	1.76	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	52.26	1.90	4.43	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	72.02	0.61	6.05	1.21	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	50.68	3.10	5.17	2.59	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	49.15	0.66	3.98	1.33	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	63.62	0.51	7.18	1.54	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	70.81	2.30	6.39	4.09	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	57.55	3.03	6.82	6.06	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	72.59	2.02	7.39	5.04	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	78.49	3.62	10.87	5.07	4.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	90.91	3.12	14.26	2.67	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	90.73	2.44	14.63	9.27	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	78.24	0.00	5.20	0.31	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	754.75	0.00	19.52	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	125.76	0.99	6.62	0.33	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	72.24	1.64	12.04	2.19	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	65.14	0.36	6.51	3.26	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	61.92	1.07	6.41	2.49	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	82.34	0.00	5.97	2.39	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	98.18	2.44	11.10	5.15	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	61.96	0.81	7.00	3.50	1.35
immature langerhans cells, donor1	11904-125F5	30.03	1.45	5.33	1.45	0.00
immature langerhans cells, donor2	11905-125F6	19.01	3.96	2.38	2.38	0.00
insula, adult, pool1	10039-101F3	86.49	7.48	4.07	3.31	4.83
keratoacanthoma cell line:HKA-1	10791-110H8	27.96	4.23	1.30	9.10	4.88
kidney, adult, pool1	10017-101C8	48.56	5.11	4.31	7.01	2.10
kidney, fetal, pool1	10045-101F9	63.17	4.17	3.75	4.17	2.97
large cell lung carcinoma cell line:IA-LM	10509-107D5	77.12	7.67	3.98	2.41	1.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	23.50	1.52	0.28	1.38	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	22.57	4.77	6.61	3.12	1.28
left atrium, adult, donor1	10079-102A7	39.23	4.36	2.18	7.08	0.54
left ventricle, adult, donor1	10078-102A6	36.41	5.56	2.53	6.07	0.51
leiomyoblastoma cell line:G-402	10721-110A1	49.25	3.28	5.75	1.09	3.28
leiomyoma cell line:10964C	10569-108B2	27.66	4.67	3.59	2.16	0.36
leiomyoma cell line:15242A	10570-108B3	25.00	1.09	1.09	3.26	1.63
leiomyoma cell line:15425	10571-108B4	37.88	3.16	3.89	1.70	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	44.96	0.00	2.09	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	56.90	3.66	2.36	1.30	2.48
liposarcoma cell line:KMLS-1	10782-110G8	31.55	3.75	3.44	1.25	1.87
liposarcoma cell line:SW 872	10726-110A6	67.86	8.65	6.21	4.02	1.83
liver, adult, pool1	10018-101C9	25.93	5.02	0.97	1.13	0.49
liver, fetal, pool1	10086-102B5	33.87	3.76	0.94	2.82	0.00
locus coeruleus - adult, donor10196	10182-103D2	78.45	4.96	6.42	6.85	4.67
locus coeruleus, adult, donor10252	10165-103B3	83.60	7.75	6.46	4.24	6.09
locus coeruleus, adult, donor10258	10375-105G6	53.04	7.90	6.21	6.49	4.51
locus coeruleus, newborn, donor10223	10362-105F2	79.08	1.26	2.10	0.42	2.94
lung adenocarcinoma cell line:A549	10499-107C4	28.09	5.67	2.35	2.35	0.97
lung adenocarcinoma cell line:PC-14	10408-106B3	26.20	4.83	2.76	4.14	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	38.75	6.20	2.24	1.58	0.26
lung, adult, pool1	10019-101D1	44.18	5.55	1.18	1.42	0.71
lung, fetal, donor1	10068-101I5	76.20	3.42	3.71	1.14	2.28
lung, right lower lobe, adult, donor1	10075-102A3	28.41	6.42	2.29	2.29	1.37
lymph node, adult, donor1	10077-102A5	37.40	5.21	0.95	0.95	2.37
lymphangiectasia cell line:DS-1	10727-110A7	33.97	6.36	3.73	1.97	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	80.90	3.17	7.55	8.75	4.08
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	73.06	6.80	7.65	5.95	0.85
mature adipocyte, donor1	12231-129F8	34.19	24.42	7.99	0.00	0.44
mature adipocyte, donor2	12232-129F9	33.62	7.06	3.53	0.62	0.21
mature adipocyte, donor3	12233-129G1	36.51	14.93	3.79	1.66	0.95
mature adipocyte, donor4	12234-129G2	47.91	5.79	3.69	1.58	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	56.71	4.77	3.81	4.53	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	81.22	2.26	4.51	4.51	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	80.73	7.36	4.05	4.41	3.49
medial frontal gyrus, adult, donor10258	10368-105F8	68.30	6.99	2.22	4.45	2.86
medial frontal gyrus, newborn, donor10223	10352-105E1	134.77	1.71	1.71	0.85	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	104.63	4.39	3.04	3.21	3.54
medial temporal gyrus, adult, donor10252	10156-103A3	85.31	7.43	5.31	3.18	4.88
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	75.12	0.00	5.78	1.93	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	488.02	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	58.86	0.00	2.15	1.44	1.79
medulla oblongata - adult, donor10196	10174-103C3	75.93	8.44	8.44	5.19	6.49
medulla oblongata, adult, donor10252	10155-103A2	81.89	11.46	6.81	5.26	6.19
medulla oblongata, adult, pool1	10038-101F2	90.20	12.00	7.67	4.82	7.10
medulla oblongata, newborn, donor10223	10361-105F1	50.69	1.74	3.47	1.74	2.08
medulloblastoma cell line:D283 Med	10838-111E1	55.35	1.99	2.44	0.44	0.66
medulloblastoma cell line:ONS-76	10759-110E3	73.73	8.31	8.07	5.50	5.14
melanoma cell line:COLO 679	10514-107E1	31.34	1.72	0.86	2.59	2.59
melanoma cell line:G-361	10465-106H6	33.66	5.43	3.26	3.53	1.36
meningioma cell line:HKBMM	10691-109F7	28.76	2.71	0.54	0.72	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	159.49	4.41	4.41	6.17	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	118.72	2.85	8.81	3.89	6.22
mesenchymal precursor cell - adipose, donor1	11747-123G1	32.37	3.84	2.45	1.69	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.27	0.91	1.09	0.55	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.42	1.66	3.31	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	26.55	2.25	1.26	0.98	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	16.75	0.58	0.96	0.77	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.13	1.39	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	19.39	3.26	1.03	0.69	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	19.21	1.96	1.50	0.69	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	26.93	2.92	1.33	1.06	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	34.71	3.38	3.78	1.76	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	34.71	4.27	2.56	1.14	1.99
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.10	1.32	1.65	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	24.77	2.91	2.35	2.49	1.52
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	25.13	1.05	1.75	1.40	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	23.89	2.45	1.63	1.02	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.13	2.88	1.80	2.88	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.14	3.00	1.14	0.62	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.50	1.60	1.37	0.46	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	36.08	3.36	10.91	1.26	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	27.20	4.93	1.79	1.20	1.20
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.13	1.93	1.66	1.14	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	33.50	4.79	2.21	1.47	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.03	4.01	2.00	0.57	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	65.26	2.53	10.95	6.74	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.01	3.20	0.46	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.35	1.53	2.05	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	24.08	1.57	2.88	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	25.57	2.77	2.46	1.23	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	26.60	1.88	1.18	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	34.86	1.02	2.03	1.02	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.51	2.75	1.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	26.88	1.39	1.39	0.46	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	37.49	2.02	3.17	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.19	1.56	1.78	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	28.36	0.96	2.40	1.20	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.20	1.47	2.93	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	29.54	0.34	0.67	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	22.11	1.64	0.82	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	28.78	0.86	1.72	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	27.93	0.97	1.95	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	1.45	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	25.59	1.60	1.07	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	2.45	1.64	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.99	0.00	2.33	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	20.86	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	19.57	2.37	1.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	2.44	2.44	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	20.27	1.27	3.17	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.90	1.03	1.38	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	2.15	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	3.44	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	14.67	2.85	0.00	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.12	1.59	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	11.79	4.72	0.59	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	16.83	2.18	0.31	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	4.01	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	2.37	3.55	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	0.00	2.57	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	23.41	3.44	1.38	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	33.15	3.46	3.96	2.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	2.24	3.36	4.49	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	34.35	3.82	4.45	5.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	29.01	4.84	3.63	4.84	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	4.36	15.26	8.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	34.21	0.00	1.27	5.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	32.17	4.25	4.86	8.50	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	9.04	9.04	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	32.95	3.29	0.82	3.29	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.03	1.79	3.17	1.59	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	27.91	1.30	1.95	1.95	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	31.58	2.04	2.04	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	44.88	3.87	0.77	1.55	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	42.76	4.96	0.94	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	44.94	6.95	3.71	6.26	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	84.56	3.39	3.29	1.54	2.36
mesothelioma cell line:Mero-25	10850-111F4	31.09	1.13	0.68	1.13	0.68
mesothelioma cell line:Mero-41	10851-111F5	64.05	3.18	6.11	2.93	1.96
mesothelioma cell line:Mero-48a	10852-111F6	36.98	1.55	0.89	1.55	1.99
mesothelioma cell line:Mero-82	10853-111F7	45.47	1.84	3.15	2.10	2.10
mesothelioma cell line:Mero-83	10854-111F8	43.24	1.53	2.55	1.36	2.04
mesothelioma cell line:Mero-84	10855-111F9	25.02	2.78	4.30	0.76	0.51
mesothelioma cell line:Mero-95	10856-111G1	35.20	1.86	1.66	3.93	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	75.04	5.80	6.96	3.64	2.32
mesothelioma cell line:NCI-H226	10846-111E9	45.79	3.62	4.52	3.80	2.53
mesothelioma cell line:NCI-H2452	10848-111F2	60.13	2.90	2.39	3.25	1.37
mesothelioma cell line:NCI-H28	10845-111E8	45.55	1.78	3.56	3.31	1.27
mesothelioma cell line:No36	10857-111G2	44.04	1.96	6.85	1.96	1.63
mesothelioma cell line:ONE58	10858-111G3	37.39	1.63	3.25	1.63	1.63
migratory langerhans cells, donor1	11901-125F2	72.93	1.34	4.41	0.96	1.73
migratory langerhans cells, donor2	11902-125F3	55.32	4.76	5.13	1.22	1.95
migratory langerhans cells, donor3	11903-125F4	58.33	3.23	2.69	1.26	2.33
mixed mullerian tumor cell line:HTMMT	10689-109F5	41.14	1.63	0.98	0.33	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	35.82	3.81	2.54	1.06	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	37.09	5.99	7.37	1.61	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	49.86	7.23	6.47	6.66	2.47
myelodysplastic syndrome cell line:SKM-1	10772-110F7	76.69	4.25	9.24	0.18	1.85
myeloma cell line:PCM6	10474-106I6	36.17	6.13	7.91	2.77	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	58.85	5.07	6.59	0.51	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	36.48	3.73	3.33	0.59	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.52	5.91	1.78	3.57	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.03	6.69	2.06	3.16	1.18
nasal epithelial cells, donor2	12227-129F4	20.42	6.62	2.76	7.18	1.10
neuroblastoma cell line:CHP-134	10508-107D4	108.82	3.22	2.76	0.69	2.99
neuroblastoma cell line:NB-1	10539-107G8	53.88	2.62	6.36	3.55	4.68
neuroblastoma cell line:NBsusSR	10607-108F4	88.15	0.84	2.32	0.00	1.48
neuroblastoma cell line:NH-12	10555-107I6	128.21	1.86	7.08	0.75	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	59.31	1.66	2.61	0.00	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	64.94	3.48	3.17	0.79	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	49.51	3.22	6.64	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	59.13	2.54	6.99	0.64	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	29.54	4.26	1.60	1.33	1.06
neutrophil PMN, donor1	12133-128D9	29.75	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	156.44	3.21	4.06	6.26	6.26
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	44.03	2.40	1.60	2.40	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	38.79	2.56	1.92	2.24	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	30.48	1.31	2.89	1.05	0.26
nucleus accumbens, adult, pool1	10037-101F1	93.36	7.78	4.59	3.37	5.25
occipital cortex - adult, donor10196	10172-103C1	105.08	4.12	0.00	0.00	6.18
occipital cortex, adult, donor10252	10163-103B1	102.25	7.51	6.44	2.15	6.98
occipital cortex, newborn, donor10223	10355-105E4	58.59	1.09	2.91	0.36	1.82
occipital lobe, adult, donor1	10076-102A4	71.90	7.87	4.99	2.36	3.15
occipital lobe, fetal, donor1	10073-102A1	138.17	8.15	7.29	3.43	2.57
occipital pole, adult, pool1	10036-101E9	54.09	4.89	2.21	1.81	2.37
olfactory region, adult	10195-103E6	68.97	5.16	4.97	2.67	2.87
optic nerve, donor1	10277-104E7	102.05	2.00	10.01	0.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	40.21	5.92	5.01	10.37	2.73
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	70.07	4.67	6.87	2.75	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	51.47	6.10	5.25	6.43	1.86
oral squamous cell carcinoma cell line:SAS	10544-107H4	34.31	3.81	4.50	2.66	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	29.40	2.35	2.65	0.88	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	118.66	12.15	3.74	4.67	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	46.02	0.64	1.91	1.91	2.54
ovary, adult, pool1	10020-101D2	55.47	1.66	0.96	0.35	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	40.88	2.93	2.02	0.55	1.47
pancreas, adult, donor1	10049-101G4	25.40	4.70	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.97	3.63	2.24	1.40	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	76.66	3.24	5.45	2.21	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	63.91	7.62	5.80	5.30	1.32
paracentral gyrus, adult, pool1	10035-101E8	79.62	6.41	3.66	2.65	4.39
parietal cortex, adult, donor10258	10373-105G4	69.00	0.00	2.94	2.20	3.67
parietal lobe - adult, donor10196	10171-103B9	99.69	2.82	3.76	3.76	4.70
parietal lobe, adult, donor10252	10157-103A4	80.10	6.84	3.42	3.14	4.28
parietal lobe, adult, pool1	10034-101E7	78.07	7.40	4.14	3.35	4.93
parietal lobe, fetal, donor1	10072-101I9	142.57	9.70	4.85	0.97	3.88
parietal lobe, newborn, donor10223	10356-105E5	66.55	0.75	2.99	1.87	1.50
parotid gland, adult	10199-103F1	35.15	4.32	1.23	2.47	0.62
penis, adult	10200-103F2	57.47	5.37	3.76	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	15.80	0.56	0.37	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	33.51	8.01	5.83	5.83	1.31
pineal gland - adult, donor10196	10179-103C8	54.18	4.52	2.58	4.52	2.58
pineal gland, adult, donor10252	10160-103A7	100.68	4.74	3.55	2.37	2.96
pineal gland, adult, donor10258	10377-105G8	64.59	3.76	2.51	0.63	2.51
pituitary gland - adult, donor10196	10180-103C9	97.13	7.08	2.02	2.02	3.04
pituitary gland, adult, donor10252	10162-103A9	119.87	6.25	8.86	4.17	6.25
pituitary gland, adult, donor10258	10378-105G9	83.42	5.96	6.81	2.55	2.55
placenta, adult, pool1	10021-101D3	54.07	3.98	1.61	4.09	1.29
plasma cell leukemia cell line:ARH-77	10840-111E3	49.66	0.93	4.50	1.19	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	34.24	2.49	1.40	1.09	0.62
pons, adult, pool1	10033-101E6	82.19	7.49	5.25	2.67	7.66
postcentral gyrus, adult, pool1	10032-101E5	72.27	7.15	3.23	3.14	3.57
promyelocytes/myelocytes PMC, donor1	12132-128D8	35.55	35.55	6.27	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	5.51	11.02	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	44.28	5.24	7.14	2.33	1.60
prostate cancer cell line:PC-3	10439-106E7	78.95	9.98	8.35	1.82	3.09
prostate, adult, pool1	10022-101D4	58.95	4.08	2.09	1.09	1.45
putamen, adult, donor10196	10176-103C5	109.30	9.21	4.25	4.72	5.67
putamen, adult, donor10252	10152-102I8	62.74	9.80	3.92	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	85.24	4.37	9.84	3.28	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	68.86	7.25	2.90	2.66	4.35
putamen, newborn, donor10223	10365-105F5	101.20	1.50	1.50	0.00	3.75
rectal cancer cell line:TT1TKB	10469-106I1	28.22	1.75	1.45	2.62	2.04
rectum, fetal, donor1	10067-101I4	68.16	5.56	6.95	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	41.13	4.66	3.39	2.33	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	59.23	8.70	1.66	0.41	0.41
retina, adult, pool1	10030-101E3	64.91	7.06	2.58	4.77	2.48
retinoblastoma cell line:Y79	10475-106I7	133.02	3.90	5.20	7.01	5.20
rhabdomyosarcoma cell line:KYM-1	10787-110H4	60.49	9.47	6.52	2.83	1.60
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	83.80	3.94	6.75	1.41	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.04	4.55	2.27	0.76	0.00
salivary acinar cells, donor1	11771-123I7	26.87	4.21	2.27	5.66	1.94
salivary acinar cells, donor2	11772-123I8	29.33	5.09	1.51	6.61	1.65
salivary acinar cells, donor3	11773-123I9	31.12	7.28	0.00	4.63	0.66
salivary gland, adult, pool1	10093-102C3	46.90	10.30	4.00	6.29	5.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	68.12	5.56	3.04	1.01	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	60.54	6.35	4.35	1.18	0.82
seminal vesicle, adult	10201-103F3	44.44	3.17	2.65	5.82	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	50.53	4.86	4.62	8.02	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	45.55	0.50	5.03	1.51	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	71.25	2.01	7.02	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	47.15	1.61	3.09	2.69	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	44.98	1.55	5.19	3.32	2.87
signet ring carcinoma cell line:NUGC-4	10483-107A6	46.19	6.06	4.13	5.03	2.97
skeletal muscle - soleus muscle, donor1	10282-104F3	106.40	3.55	9.22	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	92.11	3.24	4.20	1.44	1.20
skeletal muscle, fetal, donor1	10066-101I3	29.15	2.01	1.01	1.01	2.01
skin, adult, donor1	10074-102A2	27.14	13.57	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	68.80	5.68	1.89	2.52	4.42
small cell cervical cancer cell line:HCSC-1	10800-110I8	60.70	9.34	10.34	17.01	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	120.09	3.47	8.20	4.73	5.99
small cell lung carcinoma cell line:DMS 144	10841-111E4	56.86	6.75	4.43	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	85.87	3.30	3.79	15.00	4.78
small cell lung carcinoma cell line:NCI-H82	10842-111E5	77.37	1.45	5.95	0.48	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	111.36	9.15	8.28	12.20	1.74
small intestine, adult, pool1	10024-101D6	49.93	4.66	2.39	3.70	2.39
small intestine, fetal, donor1	10064-101I1	45.95	8.11	1.97	2.21	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	44.62	1.03	2.05	2.56	1.03
smooth muscle, adult, pool1	10048-101G3	60.48	5.69	0.78	0.00	1.29
somatostatinoma cell line:QGP-1	10781-110G7	30.29	2.41	0.80	4.56	0.54
spinal cord - adult, donor10196	10181-103D1	79.37	5.51	5.05	5.28	7.57
spinal cord, adult, donor10252	10159-103A6	77.67	11.04	5.52	7.10	11.04
spinal cord, adult, donor10258	10369-105F9	120.37	2.08	5.53	2.77	9.69
spinal cord, fetal, donor1	10056-101H2	76.84	4.27	4.27	3.66	4.88
spinal cord, newborn, donor10223	10359-105E8	93.22	1.84	4.59	2.30	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	32.86	3.73	3.14	0.90	0.60
spleen, adult, pool1	10025-101D7	45.82	4.74	1.65	0.99	2.31
spleen, fetal, pool1	10044-101F8	57.37	4.77	3.58	0.79	2.15
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	58.38	4.97	8.90	2.07	2.48
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	21.27	4.37	2.85	2.09	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	49.27	6.29	6.99	3.15	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	47.69	5.08	5.08	3.52	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	56.28	6.53	1.69	1.01	3.26
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	45.33	4.24	7.62	3.39	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	88.42	4.23	4.65	5.08	0.85
stomach, fetal, donor1	10062-101H8	42.72	5.34	5.34	5.34	3.20
submaxillary gland, adult	10202-103F4	58.68	6.27	4.56	5.13	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	54.27	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	98.87	12.25	9.14	4.15	8.93
substantia nigra, adult, donor10258	10371-105G2	79.66	3.62	7.24	4.14	2.59
substantia nigra, newborn, donor10223	10358-105E7	62.18	3.53	3.53	2.83	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	55.48	4.81	2.29	0.46	3.21
temporal lobe, adult, pool1	10031-101E4	56.71	6.19	2.63	3.48	2.20
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	119.66	4.27	4.27	2.14	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	128.78	0.88	3.08	2.20	2.64
tenocyte, donor1	11763-123H8	35.26	2.44	1.75	1.05	1.05
tenocyte, donor2	11765-123I1	30.52	3.82	2.67	1.91	0.38
tenocyte, donor3	11768-123I4	27.43	2.59	1.48	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	113.02	3.74	10.88	22.43	5.27
teratocarcinoma cell line:NCR-G1	10798-110I6	59.50	3.39	5.09	1.85	1.54
teratocarcinoma cell line:PA-1	10807-111A6	86.94	8.21	14.41	3.10	2.94
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	49.38	2.41	5.97	6.47	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	51.43	1.51	2.65	3.40	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	38.17	2.07	1.96	7.42	2.40
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	73.93	2.61	2.61	9.77	0.65
testis, adult, pool1	10026-101D8	68.40	12.13	9.99	1.61	1.40
testis, adult, pool2	10096-102C6	107.36	16.69	35.18	2.71	3.16
thalamus - adult, donor10196	10168-103B6	93.84	6.62	5.52	9.94	8.83
thalamus, adult, donor10252	10154-103A1	105.49	11.72	7.19	2.19	6.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	98.54	1.54	4.62	0.00	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	42.00	3.95	2.14	3.62	3.62
thalamus, newborn, donor10223	10366-105F6	35.67	0.58	2.30	2.88	4.03
throat, adult	10209-103G2	58.17	3.99	3.99	2.00	1.00
throat, fetal, donor1	10061-101H7	67.04	10.06	5.48	3.05	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	86.85	6.36	5.37	3.78	2.78
thymus, adult, pool1	10027-101D9	88.18	2.58	3.28	0.50	5.37
thymus, fetal, pool1	10043-101F7	112.74	4.68	3.95	1.04	11.53
thyroid carcinoma cell line:KHM-5M	10776-110G2	74.86	5.19	6.91	3.19	1.73
thyroid carcinoma cell line:TCO-1	10783-110G9	41.49	4.47	4.61	1.54	0.84
thyroid, adult, pool1	10028-101E1	62.71	4.01	2.61	1.59	2.05
thyroid, fetal, donor1	10060-101H6	57.74	7.12	4.75	4.48	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	18.48	3.08	3.08	3.08
tongue, adult	10203-103F5	67.21	3.02	3.95	3.49	3.26
tongue, fetal, donor1	10059-101H5	73.30	3.55	2.76	3.15	2.76
tonsil, adult, pool1	10047-101G2	85.85	9.02	6.41	2.50	4.81
trachea, adult, pool1	10029-101E2	46.38	5.56	2.94	2.21	1.80
trachea, fetal, donor1	10058-101H4	54.63	4.62	3.08	5.00	3.08
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	35.78	4.25	3.54	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	73.35	3.04	9.63	6.48	2.03
transitional-cell carcinoma cell line:JMSU1	10492-107B6	39.33	3.45	2.35	0.94	0.16
tridermal teratoma cell line:HGRT	10694-109G1	51.37	9.51	3.81	3.81	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	21.50	3.98	0.85	2.71	0.25
umbilical cord, fetal, donor1	10057-101H3	45.90	10.43	0.00	6.26	0.00
uterus, adult, pool1	10100-102D1	54.26	2.73	1.88	1.54	1.37
uterus, fetal, donor1	10055-101H1	66.55	6.66	5.12	2.56	2.05
vagina, adult	10204-103F6	43.30	1.94	2.58	1.29	6.46
vein, adult	10191-103E2	51.29	4.16	1.32	0.66	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	29.11	2.67	1.07	1.60	1.34